Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blinding01:11

Blinding

4.1K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
4.1K
Blind Procedures02:07

Blind Procedures

13.9K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
13.9K
Subconsciousness and No Awareness01:15

Subconsciousness and No Awareness

853
The concept of subconscious awareness refers to the processing of information below the level of conscious thought, which significantly influences both behaviors and decisions. It is also known as waking subconscious awareness. This complex level of cognition operates without the direct awareness of the individual, facilitating rapid and simultaneous handling of multiple information streams.
An illustrative example of subconscious processing is its role in problem-solving. Often, individuals...
853
Visual Agnosia01:12

Visual Agnosia

1.8K
Visual agnosia is a condition characterized by the inability to recognize visually presented objects despite having normal vision. For instance, a person with visual agnosia can describe the shape and color of an object but cannot identify or name it. This impairment does not affect their visual field, acuity, color vision, brightness discrimination, language, or memory. An example of this condition in a social setting is someone at a dinner party asking for "that silver thing with a round...
1.8K
Hindsight Biases01:12

Hindsight Biases

4.5K
Hindsight bias leads you to believe that the event you just experienced was predictable, even though it really wasn’t. In other words, you knew all along that things would turn out the way they did. Can you relate this to the phrase "Hindsight is 20/20" now? 
4.5K
Photoreceptors and Visual Pathways01:22

Photoreceptors and Visual Pathways

11.2K
At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category,...
11.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Age-dependent association of the METTL23 c.84+60delAT variant with normal-tension glaucoma.

Journal of human genetics·2026
Same author

Axial Length Growth Reference Curves and LMS Parameters for Japanese Children and Adolescents Aged 4-20 Years: The TMM BirThree Cohort Study.

Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists)·2026
Same author

Oxidative Stress in Glaucoma: From Pathogenic Mechanisms to Emerging Antioxidant Therapies.

Antioxidants (Basel, Switzerland)·2026
Same author

Comparative visual outcomes of inverted ILM flap "covering" versus "stuffed" techniques for macular hole surgery.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie·2026
Same author

Development of a machine learning model using systemic and ophthalmic parameters to detect sleep-disordered breathing in glaucoma patients.

Japanese journal of ophthalmology·2026
Same author

Three case reports of optic perineuritis complicated by ocular scleritis and hypertrophic pachymeningitis.

Journal of neuroimmunology·2026
Same journal

Guidance of Medical Care for Familial Exudative Vitreoretinopathy：Research on Rare and Intractable Diseases, Health and Labour Sciences Research Grants.

Nippon Ganka Gakkai zasshi·2018
Same journal

Steroid Resistant Vogt-Koyanagi-Harada Disease Treated Effectively with Cyclosporine.

Nippon Ganka Gakkai zasshi·2018
Same journal

The Effect of Low-dose Cyclosporine (100 mg Once Daily) for Chronic Vogt-Koyanagi-Harada Disease.

Nippon Ganka Gakkai zasshi·2018
Same journal

Clinical Classification of Degree of Deficiency in Color Defectiveness: Simulations by Changing the Total Number of Caps or Saturation of Farnsworth Dichotomous Test D-15.

Nippon Ganka Gakkai zasshi·2018
Same journal

Accelerated Epithelial Proliferation in a Rabbit Model of Bullous Keratopathy.

Nippon Ganka Gakkai zasshi·2018
Same journal

Non-infectious Uveitis and Immunosuppressants：Where We Stand and What the Future Holds.

Nippon Ganka Gakkai zasshi·2018
See all related articles

Related Experiment Video

Updated: Apr 15, 2026

A Method for Investigating Change Blindness in Pigeons Columba Livia
06:14

A Method for Investigating Change Blindness in Pigeons Columba Livia

Published on: September 7, 2018

6.8K

[Aiming for zero blindness].

Toru Nakazawa

    Nippon Ganka Gakkai Zasshi
    |April 10, 2015
    PubMed
    Summary
    This summary is machine-generated.

    This research explores new glaucoma treatments by classifying patients based on optic nerve head morphology and developing targeted drugs. Advanced imaging and big data analysis aim to improve diagnosis and discover novel therapeutic targets for preventing blindness.

    More Related Videos

    The Measurement and Treatment of Suppression in Amblyopia
    08:34

    The Measurement and Treatment of Suppression in Amblyopia

    Published on: December 14, 2012

    50.8K
    Development of a Gaze-Contingent Display Framework Designed for Perceptual and Oculomotor Research with Simulated Central Vision Loss
    07:12

    Development of a Gaze-Contingent Display Framework Designed for Perceptual and Oculomotor Research with Simulated Central Vision Loss

    Published on: April 11, 2025

    1.1K

    Related Experiment Videos

    Last Updated: Apr 15, 2026

    A Method for Investigating Change Blindness in Pigeons Columba Livia
    06:14

    A Method for Investigating Change Blindness in Pigeons Columba Livia

    Published on: September 7, 2018

    6.8K
    The Measurement and Treatment of Suppression in Amblyopia
    08:34

    The Measurement and Treatment of Suppression in Amblyopia

    Published on: December 14, 2012

    50.8K
    Development of a Gaze-Contingent Display Framework Designed for Perceptual and Oculomotor Research with Simulated Central Vision Loss
    07:12

    Development of a Gaze-Contingent Display Framework Designed for Perceptual and Oculomotor Research with Simulated Central Vision Loss

    Published on: April 11, 2025

    1.1K

    Area of Science:

    • Ophthalmology
    • Neuroscience
    • Genetics

    Context:

    • Glaucoma is a leading cause of acquired blindness, often progressing despite intraocular pressure (IOP) reduction.
    • Current treatment limitations necessitate identifying IOP-independent factors and developing novel therapies.
    • Glaucoma's complex pathology and diagnostic challenges hinder effective clinical evaluation and drug development.

    Purpose:

    • To develop methods for detailed glaucoma classification based on IOP-independent factors.
    • To advance pathology-based drug discovery using gene expression analysis and murine models.
    • To enhance glaucoma diagnosis and treatment through next-generation in vivo imaging and big data analysis.

    Summary:

    • Clinical research classified glaucoma patients into four types based on optic nerve head morphology, revealing distinct progression patterns and improving diagnostic sensitivity.
    • Pathology-based research identified endoplasmic reticulum stress (specifically CHOP) as a therapeutic target, with ongoing screening of existing drugs for inhibitors.
    • Development of advanced in vivo imaging and big data analysis infrastructure aims to visualize disease mechanisms at a cellular/molecular level and accelerate drug discovery.

    Impact:

    • Improved glaucoma classification and diagnostic methods enhance clinical trial efficiency and patient care.
    • Identification of novel therapeutic targets and drug candidates offers potential for more effective glaucoma treatments.
    • Next-generation imaging and big data analysis promise to revolutionize glaucoma diagnosis, monitoring, and the development of personalized therapies.